Actor profile

REGENXBIO

REGENXBIO pioneers gene therapy to improve lives through curative potential for rare and retinal diseases. Tracking 1 claim with 0% accuracy.

Type: organization
Tracked claims: 1
Resolved claims: 0
Accuracy: 0%

Profile

REGENXBIO pioneers gene therapy to improve lives through curative potential for rare and retinal diseases.

Recent claims

REGENXBIO expects to complete enrollment of approximately 30 patients aged 1+ in the U.S. and Canada for the AFFINITY DUCHENNE® pivotal trial of RGX-202 for Duchenne muscular dystrophy.
Aug 7, 2025